Oral iron folic acid supplementations and pregnancy outcome

To compare the effects of daily and weekly oral iron supplementations on hematological markers, GI side effects, and adherence statuses during pregnancy in healthy non-anemic pregnant women: a randomized control trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202402484795209

Enrollment

170

Registered

2024-02-02

Start date

2023-09-30

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haematological Disorders Pregnancy and Childbirth

Interventions

Twice weekly oral Iron Folic Acid supplement

daily oral iron folic acid regimen

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: - women before 25 weeks of gestation - hemoglobin level at least 11 g/dl - healthy and non-anemic - never received iron-folic acid in the current pregnancy

Exclusion criteria

Exclusion criteria: - women who disagree with consent - women who will not attend full antenatal care at the study health facility

Design outcomes

Primary

Measure	Time frame
Blood hemoglobin level in g/dl	—

Secondary

Measure	Time frame
incidence of anemia;gastric side effects;adherence status	—

Countries

Ethiopia

Contacts

Public ContactAbinet Teshome

IRB secretary at Arba Minch University and Assistant professor of Biomedical sciences

ableteshe@yahoo.com+251912023009

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026